Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs in moderate to severe systemic lupus erythematosus
NCT07041801Phase 2Recruiting
- Sponsor
- Beike Biotechnology
- Start
- Jun 2025
- Primary completion
- Sep 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in systemic lupus erythematosus (SLE), sponsored by Beike Biotechnology. Started Jun 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07041801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07041801.